$40.0 Million
Image
Skye Bioscience
Skye Bioscience
PIPE
$50.0 Million
Image
Unicycive
Unicycive Therapeutics
PIPE
$75.0 Million
Image
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
$600.0 Million
Image
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
$200.0 Million
Image
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
$30.5 Million
Image
Eagle Point Income Company Inc.
Eagle Point Income Company, Inc.
Series C Term Preferred
$100.0 Million
Image
Boundless Bio, Inc.
Boundless Bio, Inc.
Initial Public Offering
$30.0 Million
Image
milestone
Milestone Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
$410.0 Million
Image
NB
The Needham Bank
Initial Public Offering
$115.1 Million
Image
Ocular
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering